Home   About this service   Get the news  
+32 2 743 34 03

 
UCB [BE0003739530 / UCB]

UCB Media Room: Transparency notification Wellington

INFORMATION REGLEMENTEE


[03/09/2021 | 20:12]
https://mb.cision.com/Public/18595/logo/86a99b25f755738d_org.jpg

** Transparency notification Wellington
------------------------------------------------------------

=C2=B7 Notification referring to situation on 1 September 2021
=C2=B7 Threshold crossed: 7.5%
=C2=B7 Latest holding: 7.46%=C2=A0

Brussels (Belgium), 3 September 2021 =E2=80=93 20:05 (CEST) =E2=80=93 regul=
ated information

1.=C2=A0=C2=A0Summary of the notification

Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large =
shareholdings, UCB SA/NV announces that it has received a transparency noti=
fication from Wellington Management Group LLP (having its registered office=
s at 280 Congress Street, Boston, MA 02210, USA) dated 2 September 2021.

Wellington Management Group LLP has notified that, following a disposal of =
UCB shares with voting rights by its affiliates, its shareholding in UCB SA=
has decreased and it has crossed the threshold of 7.5% on 1 September 2021=
.

On 1 September 2021, Wellington Management Group LLP (taking into account t=
he holding of its affiliates) owned 14 516 633 UCB shares with voting right=
s (versus 15 575 749 shares in its previous notification dated 3 October 20=
19), representing 7.46% of the total number of shares issued by the company=
(194 505 658) (versus 8.01% in its previous notification).

2.=C2=A0 Content of the notification

=C2=B7 Reason for the notification: Acquisition or disposal of voting secur=
ities or voting rights.=C2=A0
=C2=B7 Notification by: A parent undertaking or a controlling person.
=C2=B7 Person subject to the notification requirement: Wellington Managemen=
t Group LLP, 280 Congress Street, Boston, MA 02210 (USA).
=C2=B7 Date on which the threshold is crossed: 1 September 2021.
=C2=B7 Threshold crossed (in %): 7.5%
=C2=B7 Denominator: 194 505 658.
=C2=B7 Notified details:

=C2=A0https://mb.cision.com/Public/18595/3409913/9e4a72613d8ac6c7_800x800ar=
.png
=C2=A0
=C2=B7 Chain of controlled undertakings through which the holding is effect=
ively held:=C2=A0 =C2=A0

Wellington Management Company LLP is a direct controlled undertaking of Wel=
lington Investment Advisors Holdings LLP, which, in turn, is a direct contr=
olled undertaking of Wellington Group Holdings LLP, which, in turn, is a di=
rect controlled undertaking of Wellington Management Group LLP.=C2=A0 =C2=
=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0 =
=C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0

Wellington Management International Ltd, is a direct controlled undertaking=
of Wellington Management Global Holdings, Ltd, which, in turn, =C2=A0is a =
direct controlled undertaking of Wellington Investment Advisors Holdings LL=
P, which, in turn, is a direct controlled undertaking of Wellington Group H=
oldings LLP, which, in turn, is a direct controlled undertaking of Wellingt=
on Management Group LLP.

=C2=B7 Additional information:=C2=A0

Wellington Management Company LLP is an investment management company and c=
an exercise the voting rights at its discretion in the absence of specific =
instructions from the beneficial owners of the shares.=C2=A0 =C2=A0 =C2=A0 =
=C2=A0 =C2=A0

Wellington Management International Ltd is an investment management company=
and can exercise the voting rights at its discretion in the absence of spe=
cific instructions from the beneficial owners of the shares.=C2=A0

3.=C2=A0=C2=A0Further information

This press release and the detailed transparency notification are available=
on UCB SA/NV=E2=80=99s website via the following link (https://www.ucb.com=
/investors/UCB-shareholders/Transparency-notifications) .

An updated overview of the UCB SA/NV large shareholdings will be available =
on UCB SA/NV=E2=80=99s website via the following link (https://www.ucb.com/=
investors/UCB-shareholders) .

Investor Relations
Antje Witte =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0
Investor Relations, UCB
T +32.2.559.94.14 antje.witte@ucb.com

Corporate Communications
Laurent Schots=C2=A0
Media Relations, UCB =C2=A0
T+32.2.559.92.64 =C2=A0Laurent.schots@ucb.com=C2=A0

About UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company =
focused on the discovery and development of innovative medicines and soluti=
ons to transform the lives of people living with severe diseases of the imm=
une system or of the central nervous system. With approximately 8 400 peopl=
e in nearly 40 countries, the company generated revenue of =E2=82=AC 5.3 bi=
llion in 2020. UCB is listed on Euronext Brussels (symbol: UCB). Follow us =
on Twitter: @UCB_news

GenericFile
210903 -Transparency notification press release Wellington (https://mb.cisi=
on.com/Public/18595/3409913/a10d0ab2f5c5e722.pdf) GenericFile
210903 - Notification de transparence comm de presse Wellington (https://mb=
.cision.com/Public/18595/3409913/9f12804796d05799.pdf) GenericFile
210903 - Transparantieverklaring persbericht Wellington (https://mb.cision.=
com/Public/18595/3409913/82f1930ceffd01f5.pdf) Image
Chart 1 Sept 3 2021 Transparency (https://mb.cision.com/Public/18595/340991=
3/9e4a72613d8ac6c7_org.png)

______________________
If you would rather not receive future communications from UCB SA, please g=
o to https://eu.vocuspr.com/OptOut.aspx?2973226x20421x81290x1x6868579x24000=
x6&Email=3Dregnews%40symexglobal.com.
UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium